U.S.-Japan Pilot Project In Pre-Market Collaboration Begins Soon
This article was originally published in The Gray Sheet
Executive Summary
FDA and its Japanese counterpart will soon name the two devices - one American, one Japanese - they will use in a new pilot project that could lead to faster market access for products destined for both markets, according to CDRH's Carole Carey
You may also be interested in...
Terumo Receives FDA Go-Ahead To Start Trial As Part Of U.S./Japan Pilot
Japanese device maker Terumo on May 12 announced it had received conditional U.S. FDA approval to begin enrollment for a U.S. clinical trial of its Misago superficial femoral artery stent
Terumo Receives FDA Go-Ahead To Start Trial As Part Of U.S./Japan Pilot
Japanese device maker Terumo on May 12 announced it had received conditional FDA approval to begin enrollment for a U.S. clinical trial of its Misago superficial femoral artery stent
Terumo Receives FDA Go-Ahead To Start Trial As Part Of U.S./Japan Pilot
Japanese device maker Terumo on May 12 announced it had received conditional FDA approval to begin enrollment for a U.S. clinical trial of its Misago superficial femoral artery stent